We are a Detroit-based company obsessed with helping our clients achieve the American dream of home ownership and financial freedom. We are committed to providing an industry-leading client experience powered by our award-winning culture and innovative technologies. We believe our widely recognized “Rocket” brand is synonymous with providing simple, fast, and trusted digital solutions for […]

  We are a leading, high-growth education company in Brazil powered by technology, providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment, ultimately benefiting all of our stakeholders, including students, parents, educators, administrators and private school owners. We have built a “Platform as a Service,” or PaaS, with […]

  Through our wholly owned PRC subsidiary, Khingan Forasen, we are a manufacturer and supplier of wood-based activated carbon that is primarily used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production (“Activated Carbon Production”), and a producer of biomass electricity generated in the process of producing activated carbon (“Biomass […]

(Note: This is a unit offering, but the units will not trade. Investors will be able to transact business in stock and in warrants,) Our experienced team of marketing and technology veterans has developed the Audience Cloud, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, programmatic advertising. Our platform’s open […]

  We intend to focus our search for a target business in the energy industry in North America.

We are an early clinical stage biopharmaceutical company focused on the development and testing of our lead program, PAX-101, an intravenous formulation of suramin, in the treatment of autism spectrum disorder (ASD) and the advancement of the clinical understanding of using that agent against other disorders such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID-19 […]

  We are a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging our extensive expertise in E3 ligases together with our proprietary DNA-encoded libraries, we have built DELigase, an integrated discovery platform to identify […]

  We are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. Through our in-depth understanding of the biological pathways involved in mineralization, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established […]

  Vertex delivers comprehensive tax solutions that enable global businesses to transact, comply and grow with confidence. Companies with complex tax operations rely on Vertex to automate their end-to-end indirect tax processes. Indirect tax is the largest corporate tax category, encompassing sales tax, seller’s use tax, consumer use tax and VAT, among others. Indirect tax […]

  While we may pursue an initial business combination with a company in any industry, sector or geographic location, we intend to focus our search on opportunities where we believe we can capitalize on the experience and expertise of our management team to identify, acquire and potentially operate a business in what we call the […]